X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6974) 6974
female (5415) 5415
male (5025) 5025
middle aged (5022) 5022
oncology (4644) 4644
aged (4623) 4623
chemoradiotherapy (3992) 3992
chemotherapy (3714) 3714
radiotherapy (3702) 3702
cancer (3634) 3634
adult (3529) 3529
treatment outcome (2638) 2638
surgery (2363) 2363
care and treatment (2025) 2025
neoplasm staging (1912) 1912
retrospective studies (1856) 1856
chemoradiotherapy - adverse effects (1790) 1790
antineoplastic combined chemotherapy protocols - therapeutic use (1749) 1749
aged, 80 and over (1744) 1744
radiation-therapy (1544) 1544
survival (1537) 1537
disease-free survival (1418) 1418
radiology, nuclear medicine & medical imaging (1336) 1336
carcinoma (1314) 1314
prognosis (1309) 1309
radiation therapy (1290) 1290
radiation (1273) 1273
chemoradiotherapy - methods (1246) 1246
cisplatin (1155) 1155
combined modality therapy (1155) 1155
medicine & public health (1135) 1135
hematology, oncology and palliative medicine (1132) 1132
chemoradiation (1120) 1120
analysis (1116) 1116
patients (1102) 1102
survival rate (1045) 1045
antineoplastic combined chemotherapy protocols - adverse effects (1033) 1033
cisplatin - administration & dosage (1031) 1031
therapy (1026) 1026
follow-up studies (1018) 1018
squamous-cell carcinoma (1014) 1014
toxicity (972) 972
research (971) 971
carcinoma, squamous cell - therapy (924) 924
risk factors (903) 903
radiotherapy dosage (902) 902
trial (894) 894
fluorouracil - administration & dosage (851) 851
esophageal cancer (830) 830
neoadjuvant therapy (824) 824
kaplan-meier estimate (811) 811
cancer therapies (782) 782
prospective studies (758) 758
survival analysis (757) 757
carcinoma, squamous cell - pathology (748) 748
squamous cell carcinoma (732) 732
concurrent chemoradiotherapy (728) 728
health aspects (715) 715
time factors (702) 702
metastasis (693) 693
randomized-trial (675) 675
colorectal cancer (653) 653
head and neck cancer (653) 653
young adult (642) 642
tumors (623) 623
adenocarcinoma (613) 613
adenocarcinoma - therapy (602) 602
gastroenterology & hepatology (595) 595
clinical trials (588) 588
rectal neoplasms - pathology (588) 588
rectal cancer (586) 586
rectal neoplasms - therapy (581) 581
antineoplastic agents - therapeutic use (579) 579
esophageal neoplasms - therapy (577) 577
fluorouracil (576) 576
cancer patients (569) 569
carcinoma, squamous cell - mortality (561) 561
patient outcomes (543) 543
head and neck neoplasms - therapy (542) 542
radiology (536) 536
quality of life (525) 525
multivariate analysis (510) 510
cisplatin - adverse effects (506) 506
esophageal neoplasms - pathology (506) 506
head (505) 505
oncology, experimental (505) 505
adenocarcinoma - pathology (502) 502
chemotherapy, adjuvant (500) 500
carcinoma, squamous cell - radiotherapy (495) 495
chemoradiotherapy, adjuvant (478) 478
induction chemotherapy (471) 471
nuclear radiation (462) 462
quality-of-life (460) 460
otorhinolaryngology (459) 459
antineoplastic agents - adverse effects (456) 456
carcinoma, squamous cell - drug therapy (451) 451
neck-cancer (443) 443
5-fluorouracil (441) 441
medical prognosis (439) 439
drug administration schedule (426) 426
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7607) 7607
Japanese (97) 97
French (53) 53
Chinese (47) 47
German (43) 43
Russian (19) 19
Spanish (11) 11
Hungarian (5) 5
Icelandic (2) 2
Polish (2) 2
Turkish (2) 2
Danish (1) 1
Italian (1) 1
Portuguese (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2015, Volume 33, Issue 4, pp. 332 - 339
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2013, Volume 31, Issue 31, pp. 3971 - 3979
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2011, Volume 29, Issue 32, pp. 4234 - 4242
Journal Article
Annals of oncology, ISSN 0923-7534, 2014, Volume 25, Issue 3, pp. 638 - 643
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2017, Volume 318, Issue 23, pp. 2306 - 2316
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 86, Issue 1, pp. 27 - 33
...) in reducing grade 2+ combined acute gastrointestinal and genitourinary adverse events (AEs) of 5-fluorouracil (5FU) and mitomycin-C (MMC) chemoradiation for anal cancer by at least 15... 
Radiology | Hematology, Oncology and Palliative Medicine | CANCER-PATIENTS | ONCOLOGY | CONCURRENT CHEMOTHERAPY | RANDOMIZED-TRIAL | TOXICITY | RADIOTHERAPY | FLUOROURACIL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Chemoradiotherapy - adverse effects | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Urogenital System - radiation effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Gastrointestinal Tract - radiation effects | Male | Anal Canal | Carcinoma, Squamous Cell - diagnostic imaging | Carcinoma, Transitional Cell - therapy | Radiotherapy, Intensity-Modulated - adverse effects | Radiotherapy Planning, Computer-Assisted - standards | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Aged, 80 and over | Anus Neoplasms - therapy | Adult | Dose Fractionation | Female | Mitomycin - adverse effects | Chemoradiotherapy - methods | Anus Neoplasms - diagnostic imaging | Drug Administration Schedule | Radiotherapy, Intensity-Modulated - methods | Carcinoma, Squamous Cell - therapy | Anus Neoplasms - pathology | Radiography | Analysis of Variance | Carcinoma, Transitional Cell - pathology | Radiation Injuries - prevention & control | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Neoplasm Staging | Mitomycin - administration & dosage | Sects | Mitomycin | Nuclear radiation | Analysis | Clinical trials | Radiotherapy | Cancer | Fluorouracil | Index Medicus | AUGER ELECTRON SPECTROSCOPY | REVIEWS | PATIENTS | DISEASE INCIDENCE | URACILS | RADIATION QUALITY | METASTASES | MITOMYCIN | RADIATION DOSES | PLANNING | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2014, Volume 32, Issue 25, pp. 2735 - 2743
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 94, Issue 5, pp. 1052 - 1060
Purpose/Objective(s) To quantify ensuing bone marrow (BM) suppression during postoperative chemotherapy resulting from preoperative chemoradiation (CRT)... 
Radiology | Hematology, Oncology and Palliative Medicine | PROGENITOR CELLS | COLON-CANCER | MODULATED RADIATION-THERAPY | ACUTE HEMATOLOGIC TOXICITY | STEM-CELLS | ONCOLOGY | PHASE-III | DOSIMETRIC PREDICTORS | CERVICAL-CANCER | ADJUVANT THERAPY | COMBINATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Capecitabine - administration & dosage | Leucovorin - administration & dosage | Chemoradiotherapy - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Bone Marrow Diseases - etiology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bone Marrow - radiation effects | Neutropenia - etiology | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Statistics, Nonparametric | Female | Rectal Neoplasms - pathology | Retrospective Studies | Bone Marrow - drug effects | Ilium - radiation effects | Lumbar Vertebrae - radiation effects | Thrombocytopenia - etiology | Logistic Models | Rectal Neoplasms - therapy | Preoperative Care | Pelvic Bones - radiation effects | Capecitabine - adverse effects | ROC Curve | Leukopenia - etiology | Organoplatinum Compounds - adverse effects | Sacrum - radiation effects | Medical colleges | Cancer patients | Care and treatment | Chemotherapy | Colorectal cancer | Cancer | Complications and side effects | Index Medicus | PATIENTS | INHIBITION | NEOPLASMS | RECTUM | GY RANGE 01-10 | RADIOLOGY AND NUCLEAR MEDICINE | BONE MARROW | RADIATION DOSES | FLUORINE COMPOUNDS | GY RANGE 10-100 | CHEMOTHERAPY
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 509 - 518
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2017, Volume 98, Issue 2, pp. 409 - 418
Journal Article
The Lancet (British edition), ISSN 0140-6736, 01/2019, Volume 393, Issue 10166, pp. 51 - 60
The incidence of human papillomavirus (HPV)-positive oropharyngeal cancer, a disease affecting younger patients, is rapidly increasing. Cetuximab, an epidermal... 
yes | DYSPHAGIA | HEAD | MEDICINE, GENERAL & INTERNAL | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | P16 STATUS | ASSOCIATION | EXPRESSION | NECK-CANCER | Oropharyngeal Neoplasms - therapy | Chemoradiotherapy - adverse effects | Humans | Middle Aged | Squamous Cell Carcinoma of Head and Neck - pathology | Male | Antineoplastic Agents - therapeutic use | Oropharyngeal Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Cetuximab - therapeutic use | Radiotherapy, Intensity-Modulated - adverse effects | Squamous Cell Carcinoma of Head and Neck - virology | Cetuximab - adverse effects | Cisplatin - administration & dosage | Antineoplastic Agents - adverse effects | Female | Acute Disease | Chemoradiotherapy - methods | Papillomavirus Infections - complications | Drug Administration Schedule | Risk Assessment | Radiotherapy, Intensity-Modulated - methods | Kaplan-Meier Estimate | Treatment Outcome | Oropharyngeal Neoplasms - virology | Cisplatin - therapeutic use | Cisplatin - adverse effects | Cetuximab - administration & dosage | Squamous Cell Carcinoma of Head and Neck - therapy | Neoplasm Staging | Papillomaviruses | Radiotherapy | Throat cancer | Papillomavirus infections | Head | Intravenous administration | Toxicity | Health risks | Risk | Radiation therapy | FDA approval | Cancer therapies | Patients | Evidence-based medicine | Cisplatin | Quality of life | Human papillomavirus | Randomization | Epidermal growth factor | Motivation | Oropharyngeal cancer | Head and neck | Head & neck cancer | Growth factors | Smoking | Cancer | Tumors
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 983 - 991
Purpose To determine how chemotherapy agents affect radiation dose parameters that correlate with acute hematologic toxicity (HT) in patients treated with... 
Radiology | Hematology, Oncology and Palliative Medicine | CISPLATIN | IMRT | ONCOLOGY | PREDICTORS | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | CERVICAL-CANCER | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Chemoradiotherapy - adverse effects | Humans | Middle Aged | Male | Bone Marrow - radiation effects | Antineoplastic Agents - administration & dosage | Pelvis | Radiotherapy, Intensity-Modulated - adverse effects | Cisplatin - administration & dosage | Prostatic Neoplasms - therapy | Neutropenia - etiology | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Anus Neoplasms - therapy | Female | Lymphatic Irradiation - adverse effects | Retrospective Studies | Bone Marrow - drug effects | Lymphatic Irradiation - methods | Mitomycin - adverse effects | Radiotherapy Dosage | Chemoradiotherapy - methods | Ilium - radiation effects | Drug Administration Schedule | Thrombocytopenia - etiology | Radiotherapy, Intensity-Modulated - methods | Probability | Logistic Models | Rectal Neoplasms - therapy | Radiation Tolerance - drug effects | Radiography | Pelvic Bones - radiation effects | Regression Analysis | Lumbosacral Region - radiation effects | Genital Neoplasms, Female - therapy | Cisplatin - adverse effects | Aged | Leukopenia - etiology | Mitomycin - administration & dosage | Pelvic Bones - diagnostic imaging | Chemotherapy | Models | Radiotherapy | Nuclear radiation | Cancer | Index Medicus | PROSTATE | URACILS | NEOPLASMS | RECTUM | PLATINUM | BONE MARROW | MITOMYCIN | RADIATION DOSES | TOXICITY | CHEMOTHERAPY | VERTEBRAE | RADIOLOGY AND NUCLEAR MEDICINE | PELVIS | LEUKOPENIA
Journal Article